![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Previous Article | Next Article 
Infection and Immunity, July 2002, p. 3804-3815, Vol. 70, No. 7
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.7.3804-3815.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Pharmacological Sciences and Experimental Medicine,1 Department of Molecular, Cellular, and Animal Biology, University of Camerino, 62032 Camerino,4 Department of Experimental Medicine and Pathology,3 Department of Human Physiology and Pharmacology, University "La Sapienza," 00161 Rome, Italy2
Received 15 January 2002/ Returned for modification 12 February 2002/ Accepted 20 March 2002
 |
ABSTRACT |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
vß3 and vß5 integrin-like on C. albicans either by specific monoclonal antibodies or upon adhesion to VN or EA.hy 926 endothelial cells stimulates CaFak tyrosine phosphorylation that is blocked by PTK inhibitor. A role for CaFak in C. albicans yeast adhesion was also supported by the failure of VN to stimulate its tyrosine phosphorylation in a C. albicans mutant showing normal levels of CaFak and VNR-like integrins but displaying reduced adhesiveness to VN and EA.hy 926 endothelial cells. Our results suggest that C. albicans Fak-like protein is involved in the control of yeast cell adhesion to VN and endothelial cells. |
INTRODUCTION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Integrins are a large family of highly conserved heterodimers composed of noncovalently linked and ß subunits that mediate cell-matrix and cell-cell interactions in embryogenesis, hemostasis, wound healing, tumor and microorganism invasion, immune response, and inflammation (25, 38). These receptors mediate the tight adhesion of cells to the ECM at sites referred to as focal adhesions. Within focal adhesions, the cytoplasmic domains of the integrin heterodimers provide a site to which cytoskeletal proteins are tethered. In addition to their structural roles, several findings indicate that integrins also play a role in cellular signaling (11, 15, 19). Engagement of integrins with their cognate ligands or with specific antibodies (Abs) induces a number of signaling events within the cell, including changes of pH and intracellular Ca2+ concentration, stimulation of tyrosine phosphorylation of a number of cellular proteins, and induction of gene expression. Since the integrins contain short cytoplasmic domains that exhibit no enzymatic activity, these cellular signals must be elicited through intermediary signaling proteins, namely, protein tyrosine kinases (PTKs). The cytosolic PTKs implicated in integrin-mediated signaling include members of Fak, Src, and Zap70/Syk families (11, 15).
The Fak family consists of two evolutionarily conserved PTKs localized in the focal adhesions, namely, p125Fak and Pyk-2 (8, 36, 43). The cDNA encoding p125Fak has been isolated from different species and shows a high level of homology that reaches 95% identity at the amino acid level. A number of studies have shown that Fak functions as part of a cytoskeletal-associated network of signaling proteins, including p130Cas, Shc, and Grb-2, which act in combination to transduce integrin-generated signals to mitogen-activated protein kinase (MAPK) cascades (44). Tyrosine phosphorylation of the Fak family is regulated by different stimuli which include adhesive events, in that several components of the ECM, such as fibronectin (FN), vitronectin (VN), laminin, and collagen IV, or clustering of ß1, ß3, ß5, and ß7 integrins trigger p125Fak tyrosine phosphorylation (5, 15, 29).
Accumulating evidence also indicate that Fak tyrosine phosphorylation is important for cell migration. Indeed, experiments employing Fak null cells, Fak overexpression, or dominant-negative Fak constructs have established the requirement for Fak in integrin-stimulated cell migration (20, 26, 35). Moreover, expression of the protein tyrosine phosphatase PTEN leads to Fak dephosphorylation and the inhibition of cell motility (47).
We have recently reported in C. albicans yeasts the presence of vß3 and vß5 integrin-like VN receptors (VNRs) that mediate specific adhesion to VN, and the involvement of VN in yeast adhesion to human endothelial cell line (45). Moreover, the existence in C. albicans and in less-pathogenic Candida species of surface proteins antigenically, structurally, and functionally related to the 5ß1 integrin FN receptor has been previously demonstrated (39, 40). There is also evidence that C. albicans expresses an INT1 gene encoding a surface protein, InT1p, structurally related to M and X subunits of the ß2 integrin (18).
The study of signal transduction pathways in virulent fungi is especially important in view of their putative implications in the regulation of pathogenicity. In this regard, a crucial role in the control of Candida adherence, hyphal development, and virulence has been shown for Ras-related GTPase (53), homologues of serine-threonine p21-associated kinase (PAK) (29) and MAPK cascade components (16, 32), phosphoinositide-3 kinase (PI-3K) (4), and for CaHK1 histidine kinase (7).
However, although a number of phosphate-containing proteins have been shown in the C. albicans cell wall (9), and stimulation of tyrosine phosphorylation of several substrates was described in Candida yeast cells adherent to epithelial cells (2), the role of PTKs and tyrosine phosphorylation in the regulation of C. albicans adherence to ECM and to host cells has been poorly elucidated.
The present study sought to determine whether a putative vertebrate p125Fak homologue that we termed CaFak is expressed in C. albicans yeast cells and whether cross-linking of the vß3 and vß5 integrin-like receptors or adhesion to VN or a human endothelial cell line can regulate its tyrosine phosphorylation.
|
MATERIALS AND METHODS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Yeasts were cultured into Sabouraud dextrose agar (SDA; Becton Dickinson Microbiology Systems, Cockeysville, Md.), frozen at -80°C in small volumes in Sabouraud dextrose broth containing glycerol 5%, and subcultured monthly in SDA. For assays, a loopful of yeast cells was removed from the agar slant, washed twice with cold phosphate-buffered saline (PBS) by centrifugation at 3,000 rpm, and grown to mid-exponential phase at 24°C in Sabouraud dextrose broth. Growth curves were determined spectrophotometrically by measurement of the optical density at 420 nm and a simultaneous count.
Human EA.hy 926 endothelial cell line culture. The human EA.hy 926 endothelial cell line (33) was maintained in Dulbecco modified Eagle medium (Gibco-BRL/Life Technologies, Milan, Italy) supplemented with 10% heat-inactivated fetal calf serum (BioWhittaker Europe, Vewiers, Belgium), 2% hypoxanthine-aminopterin-thymidine, 2 mM HEPES, 2 mM L-glutamine, 100 IU of penicillin/ml, and 100 mg of streptomycin/ml. Third- or fourth-passage cells were utilized for adhesion assay.
Abs, adhesive proteins, and reagents.
The following mouse monoclonal Abs (MAbs) were used: anti-NH2 terminus of chicken Fak (immunoglobulin G [IgG]; anti-Fak NH2) was provided by Guido Tarone, University of Turin, Turin, Italy (14); anti-central domain (residues 354 to 533) of chicken Fak (clone 77, IgG1) was purchased from Transduction Laboratories, Lexington, Ky.; anti-human vß3 (clone LM609, IgG1) and anti-human vß5 (clone P1F6, IgG1; Chemicon International, Inc., Temecula, Calif.); anti-human VN (clone VIT-2, IgG1; Sigma Chemical Co., St. Louis, Mo.); and anti-phosphotyrosine (pTyr) (clone 4G10, IgG2b; Upstate Biotechnology). A MAb to a cell surface glucomannoprotein (GMP) constituent of C. albicans (clone GF2, IgG1) was kindly provided by A. Cassone (48), and anti-rat CD5 (clone OX-19, IgG1) was obtained from Pharmingen, Palo Alto, Calif.
The following rabbit polyclonal Abs were used: antiserum directed to the COOH domain of chicken Fak (anti-Fak COOH), antiserum directed against an intracytoplasmic domain of the human ß3 integrin, and antiserum directed to the COOH domain of the human v integrin (kindly provided by Guido Tarone), antiserum to a COOH-terminal sequence of the human ß5 integrin (Bioline Diagnostic, Turin, Italy), and anti-human VN Ab (Gibco-BRL).
Normal rabbit serum from Cappel-Organon Teknika or affinity-purified rabbit anti-mouse IgG (RAM; Zymed Laboratories, Inc., San Francisco, Calif.) was used as a negative control in immunoprecipitation studies. Horseradish peroxidase-conjugated sheep anti-mouse IgG (Amersham Pharmacia Biotech, Uppsala, Sweden) was used in immunoblotting. Purified fluorescein isothiocyanate (FITC)-conjugated goat F(ab')2 fragments of anti-mouse (GAM) and anti-rabbit (GAR) IgG were purchased from Cappel-Organon Teknika, Turnhout, Belgium, and Dako, Copenhagen, Denmark, respectively; purified Texas Red-conjugated F(ab')2 GAM was purchased from Molecular Probes, Inc., Eugene, Oreg.
Human VN was purchased from Gibco-BRL/Life Technologies. Bovine serum albumin (BSA) and poly-L-lysine were purchased from Sigma, and fibrinogen (Fb) was obtained from Calbiochem-Novabiochem, La Jolla, Calif.
The PTK inhibitors herbimycin A and genistein were purchased from Sigma and Calbiochem-Novabiochem, respectively.
Immunofluorescence and flow cytometry. C. albicans yeast cells were permeabilized, and immunofluorescence and flow cytometric analysis were performed with the anti-Fak COOH rabbit antiserum or the following MAbs: anti-Fak NH2 or anti-Fak clone 77. Normal rabbit serum, isotype-matched (IgG1) anti-rat CD5 or anti-GMP (GF2) mouse MAb were used as negative controls.
Briefly, 106 C. albicans yeast cells/ml suspended in PBS at 1% of saponin from Quillaja Bark (Sigma) and 1% ethanol (EtOH; Baker, B.V. Deventer, Holland) were incubated at 37°C, stirred for 30 min, and then washed twice with cold PBS plus 0.1% saponin (45). Aliquots of 106 C. albicans yeast cells were incubated with 50 µl of the first Ab properly diluted (1:25) for 30 min at 4°C and then washed twice with 2 ml of cold PBS without calcium and magnesium (Euroclone, Ltd.). Cells were then incubated with 20 µl of the FITC-GAM or -GAR secondary Ab (1:20) for 30 min at 4°C, washed twice with 2 ml of cold PBS, and resuspended in 0.5 ml of PBS.
The expression of vß3 and vß5 integrin-like VNRs on the clinical isolate of C. albicans or the mutagenized C. albicans 3153 yeast cells was evaluated by using anti-vß3 and anti-vß5 MAbs as previously described (45).
The yeast phase was verified microscopically and was not less than 97%.
The cell populations were analyzed for the percentage of positively stained cells, determined over 10,000 events on a FACScan cytofluorimeter (Becton Dickinson, Mountain View, Calif.). Fluorescence intensity is expressed in arbitrary units on a logarithmic scale.
Confocal scanning microscopy.
A total of 2 x 106 cells of C. albicans grown as described above were pelleted by centrifugation at 3,000 rpm, spread on slides, fixed at 50°C, and dried at room temperature (RT) with 60% EtOH solution and absolute EtOH (3) for 2 and 3 min, respectively. Thereafter, yeasts were incubated for 15 min at 37°C, with 20 µg of proteinase K (Boehringer Mannheim, Mannheim, Germany)/ml, washed in PBS, and covered for 3 min with absolute EtOH. Then, 1% BSA in PBS-Tween 20 was added for 30 min, and cells were incubated for 1 h at RT with 100 µl of the following Abs: anti-Fak (clone 77), anti-Fak NH2, anti-GMP (GF2), or anti-rat CD5 (OX-19) MAb, rabbit anti-Fak COOH polyclonal Ab (1:50), or normal rabbit serum. After incubation, cells were washed three times for 10 min each time and three times for 5 min each time with the same buffer. Finally, yeasts were incubated with 100 µl of FITC-GAR or -GAM (1:100) for 30 min at RT, washed as described above, and then covered with glycerol. Candida permeabilization was checked by pretreating yeast cells with 0.5 mg of propidium iodide (Sigma)/ml for 2 min at RT. In some experiments, 7 x 105 C. albicans yeast cells were allowed to adhere for 30 min at 37°C and 5% CO2 to chamber slides coated with 10 µg of VN/ml. Unattached cells were removed by extensive washing with warm PBS, and adherent C. albicans yeast cells were fixed, permeabilized, and stained with anti-Fak NH2, MAb, or anti-Fak COOH rabbit polyclonal Ab as described above. Moreover, C. albicans yeast cells adherent to VN were fixed and permeabilized as described above and then stained for 1 h at 4°C with 100 µl of anti-Fak NH2 MAb and 100 µl of rabbit anti-v, anti-ß3, or anti-ß5 integrin antiserum. Samples were then washed three times for 5 min each time with the same buffer and incubated with 100 µl of Texas Red-GAM (1:100) and FITC-GAR (1:60) for 1 h at 4°C, washed three times, and mounted as described above.
All samples were analyzed by using a Bio-Rad MRC600 confocal laser-scanning microscope attached to a Nikon (Diaphot-TMD) inverted microscope with an 60x NA, 1.4 oil immersion lens with an argon-krypton laser operating at an excitation wavelength of 494 nm and with an emission filter of 520 nm. Pairs of images were collected simultaneously in the green channel for confocal image and in the transmission detector for a phase-contrast image at least twice. For colocalization studies, fluorochromes were excited with the 600 line of the argon-krypton laser and imaged by using a 488- or 588-nm bandpass filter. Serial optical sections 1 µm thick were taken for each cell; only one central optical section is shown. Data were acquired and processed by using Comos Bio-Rad software. Intensities were streched to fill the 256 step of the gray scale. The fluorescent image was superimposed in a suitable pseudocolor upon the transmission image with a software command "merge."
Cell stimulation.
A total of 108 C. albicans yeast cells diluted in PBS were stimulated with anti-vß3, anti-vß5, or anti-GMP (GF2) MAb (1 µg/5 x 106 cells) for different times (0, 10, 30, and 60 min) at 37°C or allowed to adhere to VN-, BSA-, Fb-, and poly-L-lysine (10 µg/ml)-coated surfaces.
Binding experiments were performed with C. albicans yeast cells and paraformaldehyde-prefixed EA.hy 926 endothelial cells (yeast/EA.hy 926 cell ratio = 100:1) as previously reported (21). Briefly, EA.hy 926 cells starved for 2 h at 37°C and 5% CO2 in phosphate-free RPMI 1640 medium were pelleted and treated with PBS-1% paraformaldehyde for 30 min at RT in a shaker. EA.hy 926 cells were then washed three times in PBS-1% BSA and resuspended in Dulbecco modified Eagle medium.
In some experiments C. albicans yeast cells cultured in YPD medium (1% yeast extract, 2% Bacto Peptone, 2% dextrose; Difco Laboratories, Detroit, Mich.) were pretreated with 10 µM herbimycin A or vehicle (dimethyl sulfoxide [DMSO]) at the same dose for 16 h at RT and then allowed to adhere to VN at 10 µg/ml or paraformaldehyde-prefixed EA.hy 926 confluent cell monolayers.
Immunoprecipitation and Western blotting. C. albicans yeast cells grown in SDA as described above described were washed three times in PBS and then resuspended in 0.4 ml of radioimmunoprecipitation assay buffer (0.15 M NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate [SDS], 0.05 M Tris, 4 mM phenylmethylsulfonyl fluoride, 2 mg of aprotinin/ml, 0.1 mM Na3VO4) to which an equal volume of 500-µm nitric acid-washed glass beads (Sigma) was added. Cell suspensions were then vortexed for 2 min and left for 1 min on ice, and the procedure was repeated 8 to 10 times. Lysates were centrifuged at 14,000 x g for 10 min at 4°C and immunoprecipitated. Briefly, lysates were precleared for 1 h at 4°C with 150 µl of 20% suspension of protein A-Sepharose CL-4B (Pharmacia, Uppsala, Sweden). Precleared lysates were then combined with protein A-Sepharose CL-4B preconjugated with rabbit polyclonal anti-Fak COOH, or normal rabbit serum or RAM used as negative control, and incubated overnight at 4°C. Immunocomplexes were then washed seven times with washing buffer (10 mM Tris; 30 mM NaCl; 1 mM EDTA; 0.03% NaN3; 0.25% Nonidet P-40; 0.1% SDS; 0.1% deoxycholate; 0.1% BSA, pH 7.4) and three times with the same buffer without BSA. Bound proteins were released by boiling them in reducing buffer and then centrifuged at 14,000 x g for 2 min. Samples were analyzed by SDS-polyacrylamide gel electrophoresis on 7.0% polyacrylamide gels and then electrotransferred overnight onto polyvinylidene difluoride membranes (Immobilon-P; Millipore) at 4°C and 20 V with a Trans-Blot Electrophoretic Transfer Cell (Bio-Rad). The membrane was then incubated with a blocking solution (5% BSA-0.05% Tween 20 in PBS) for 60 min at RT and washed four times with washing buffer. Thereafter, the membrane was incubated for 2 h at RT with one of the following mouse MAbs: anti-Fak NH2, anti-Fak (clone 77), or irrelevant anti-rat CD5 at a 1:500 dilution in PBS-Tween.
The membrane was washed three times for 10 min each time and three times for 5 min each time with PBS-Tween at RT and then incubated for 1 h with horseradish peroxidase-conjugated sheep anti-mouse IgG at a 1:10,000 dilution (Amersham Life Sciences). The immunoreactivity was detected by using an enhanced chemiluminescence kit (Amersham Life Sciences) according to the manufacturer's instructions.
Adhesion assay to ECM proteins or to EA.hy 926 human endothelial cell line. Stock preparations of human VN were diluted in PBS (pH 7.4) at a concentration of 1 µg/ml. Protein solution (100 µl) was distributed in 96-well tissue culture flat-bottom plates (Costar, Cambridge, Mass.). After overnight incubation at 4°C, coated plates were washed three times with cold PBS to remove nonimmobilized protein.
Then, 3 x 104 human EA.hy 926 endothelial cells were grown to confluence for 24 h at 37°C in 5% CO2 in collagen-coated 96-well tissue culture flat-bottom microtiter plates (Costar).
C. albicans yeasts were labeled with [3H]glucose (NET- 807; D-[6-3H]glucose specific activity of 1.29 TBq/mmol, 37 MBq, 35.0 Ci/mmol; Amersham Life Sciences). Briefly, yeast cells (108) were labeled with [3H]glucose (20 mCi) in 1 ml of PBS for 3 h at RT. After labeling, microorganisms were washed twice in cold PBS and resuspended at 5 x 106/ml in PBS.
C. albicans yeast cells were pretreated with different doses of genistein (10, 50, 100, or 200 µM) or vehicle (DMSO) for 1 h at 37°C in PBS or of herbimycin A (1, 5, 10, or 50 µM) or vehicle (DMSO) in YPD medium for 16 h at RT and then radiolabeled as described above. Finally, untreated, genistein-treated, herbimycin A-treated, or vehicle-treated C. albicans yeast cells were allowed to adhere to VN or EA.hy 926 confluent cell monolayers for 30 min or 1 h at 37°C in 5% CO2, respectively.
Adhesion was also verified microscopically; the yeast phase was maintained throughout the adhesion assay, and agglutination was not observed. Unattached cells were removed by extensive washing with warm PBS, and yeast cells adhered to VN or EA.hy 926 endothelial cells were harvested by adding twice 100 µl of bleach for 10 min at RT with a cell scraper. Bound counts per minute (cpm), as well as cpm from nonadherent cells plus washes, were quantitated in a ß-scintillation counter. Quadruplicate wells were assayed for each sample.
To rule out the contribution of C. albicans binding to plastic in the adhesion to VN, assays were always performed in the presence of a dose of anti-VN MAb (VIT-2) or a rabbit anti-VN antiserum, which maximally inhibited cell binding to VN, while it did not substantially affect cell binding to the plastic surface, as previously described (45). Cell adhesion was calculated as follows: [adherent cells (in cpm)/total cells (in cpm)] x 100, where the total cpm indicates the sum of nonadherent cells, washes, and adherent cell cpm. This value routinely exceeded 95% of total cell counts. Specific binding to VN was calculated as the difference between the total percent adhesion and the percent adhesion not inhibited by anti-VN Ab (nonspecific adhesion).
Statistical analysis. Statistical analysis by Student's t test was performed by the STATPAC Computerized Program, and a P value of <0.01 was used as the significance criterion.
|
RESULTS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
As shown in Fig. 1, both genistein and herbimycin A markedly inhibit yeast cell adhesion to VN and the EA.hy 926 endothelial cell line in a dose-dependent manner, indicating that tyrosine kinase activation is a crucial signaling event required for C. albicans adhesive interactions with VN and the human endothelial cell line.
|
Immunoprecipitation and Western blotting analysis of C. albicans yeast cell lysates with the rabbit anti-Fak COOH polyclonal Ab reveals a protein of 105 kDa and a doublet migrating at 52 to 55 kDa. The higher band at 105 kDa (CAFak) approximates the molecular mass of human Fak (116 kDa) (15) and migrates slightly faster than the Fak protein immunoprecipitated from the human endothelial cell line used as positive control (Fig. 2A ). The identity of the lower bands present in both C. albicans and EA.hy 926 cell immunoprecipitates is currently unknown but likely corresponds to the p125Fak truncated isoform consisting of the COOH-terminal noncatalytic domain, p41/43FRNK (Fak-related nonkinase) (15) or to Fak proteolytic fragments (44).
|
As shown in Fig. 2B, both the anti-Fak NH2 MAb and the anti-Fak antiserum positively stained (74 and 67.%, respectively) C. albicans yeast cells. Similar results were obtained by using the other anti-Fak MAb (data not shown), whereas no significant reactivity was observed with an irrelevant isotype-matched MAb or normal rabbit serum used as negative controls.
Finally, confocal microscopy on permeabilized C. albicans yeast cells with the anti-Fak NH2 MAb indicated that CaFak protein is mainly distributed in the cytosol (Fig. 2C). Similar results were obtained with the anti-Fak (clone 77) MAb or the rabbit anti-Fak antiserum (data not shown), whereas no significant reactivity was observed with an irrelevant isotype-matched MAb or normal rabbit serum used as negative controls.
Altogether, these results indicate that C. albicans in the yeast phase expresses a p105Fak-like protein, CaFak, showing an antigenic similarity with the vertebrate p125Fak PTK.
CaFak and integrin-like receptors colocalization is induced in C. albicans yeast cell upon adhesion to VN.
Fak is a cytoplasmic protein kinase that in multicellular organisms localizes to focal adhesions upon cell interaction with ECM proteins. Moreover, in adherent cells also integrins localize into the focal contacts, where they codistribute with cytoskeleton proteins including vinculin, -actinin, paxillin, tensin, and signaling molecules such as p125Fak (15).
Thus, to support the hypothesis that in C. albicans CaFak may play a role in the intracellular signaling pathways initiated by integrin-like receptors, we evaluated the localization of CaFak and integrin-like receptors in C. albicans yeast cells upon adhesion to VN.
Confocal microscopy analysis on permeabilized adherent C. albicans yeast cells with a rabbit anti-Fak COOH antiserum or the anti-Fak NH2 MAb (data not shown) indicated that, upon adherence of C. albicans yeast cells to VN, CaFak translocates from the cytosol to the membrane and localizes to the focal contacts (Fig. 3). Moreover, we found that upon C. albicans adhesion to VN, CaFak colocalizes with v, ß3, and ß5 integrin-like receptors (Fig. 3). No significant reactivity was observed with an irrelevant isotype-matched mouse MAb or normal rabbit serum used as negative controls (data not shown).
|
vß3 and vß5 integrin-like VNRs on C. albicans.
A large number of studies indicate that p125Fak is tyrosine phosphorylated in adherent cells, and its tyrosine phosphorylation status increases upon engagement of integrins with their cognate ligands or with specific Abs (5, 8, 22, 29, 36, 42).
We have previously demonstrated that C. albicans yeast cells express vß3 and vß5 integrin-like VNRs that mediate their adhesion to VN (45).
We therefore tested whether ligation of vß3 and vß5 integrin-like VNRs on C. albicans yeast cells by the natural ligand VN or specific MAb results in CaFak tyrosine phosphorylation. C. albicans yeast cells were left untreated or were treated for different times with anti-vß3, anti-vß5 MAb, or with anti-GMP MAb used as control. Lysates from stimulated or unstimulated cells were immunoprecipitated with a rabbit anti-Fak COOH polyclonal Ab and blotted with an anti-pTyr or anti-Fak NH2 MAb (Fig. 4). Ab-mediated cross-linking of vß3- or vß5-like integrins on C. albicans yeasts stimulates CaFak tyrosine phosphorylation that is already evident at 10 min, is maximal at 30 min, and declines at 60 min after stimulation. A basal phosphorylation of this protein was evident in yeast cells, although the levels varied from experiment to experiment. No consistent changes in the tyrosine phosphorylation status of CaFak were observed when C. albicans yeast cells were treated with a control MAb. All immunoprecipitates contained comparable levels of CaFak protein, as evaluated by Western blot analysis. Immunoprecipitates of C. albicans yeast cell lysates with anti-GMP MAb (clone GF2) or an irrelevant rabbit polyclonal Ab, when blotted with anti-pTyr MAb, did not reveal any band (data not shown), indicating that the anti-phosphotyrosine MAb employed in our study specifically reacts with tyrosine-phosphorylated proteins also in Candida.
|
vß3- or vß5-like integrins (Fig. 5A). Conversely, no changes in the basal level of CaFak tyrosine phosphorylation were observed upon adhesion to Fb, BSA, or poly-L-lysine (Fig. 5B). All immunoprecipitates contained comparable levels of CaFak protein as evaluated by Western blot analysis. Moreover, pretreatment of C. albicans with the tyrosine kinase inhibitor, herbimycin A, completely inhibited the increased CaFak tyrosine phosphorylation stimulated by yeast cell adhesion to VN.
|
vß3 and vß5 integrin-like VNRs by specific Abs or the natural ligand VN. Tyrosine kinase activation is required for stimulation of CaFak tyrosine phosphorylation upon adhesion of C. albicans yeast cells to the EA.hy 926 human endothelial cell line. In order to investigate the involvement of CaFak tyrosine phosphorylation in C. albicans yeast cell adhesion to the EA.hy 926 endothelial cell line, yeast cells were stimulated with prefixed endothelial cells for different times at 37°C. Cell lysates were then immunoprecipitated with a rabbit anti-Fak COOH polyclonal Ab and blotted with anti-pTyr or anti-Fak NH2 MAb (Fig. 6). Interaction of C. albicans yeast cells with EA.hy 926 endothelial cells stimulates CaFak tyrosine phosphorylation that is already evident 10 min after binding, reaches maximal levels at 30 min, and declines at 60 min. In addition, pretreatment of C. albicans yeast cells with herbimycin A downmodulates CaFak tyrosine phosphorylation induced by C. albicans interaction with the endothelial cell line.
|
We initially tested the expression of integrin-like VNRs and CaFak in this C. albicans mutant strain, as well as its ability to adhere to VN or the EA.hy 926 endothelial cell line (Fig. 7).
|
vß3 and vß5 integrin-like VNRs and CaFak proteins with respect to the C. albicans clinical isolate, as evaluated by immunofluorescence and fluorescence-activated cell sorting (FACS) analysis. However, the mutant C. albicans strain exhibits a defective adhesiveness to VN or to the endothelial cell line at any time point tested compared to the C. albicans clinical isolate (Fig. 7B). We then examined whether interaction of mutagenized C. albicans yeast cells with VN was capable of stimulating CaFak tyrosine phosphorylation. Yeast cells were allowed to adhere for different times at 37°C on VN-coated plates. Yeast cell lysates were then immunoprecipitated as described above (Fig. 8). Unlike the clinical isolate of C. albicans, adhesion of the mutant strain to VN resulted in a time-dependent tyrosine dephosphorylation of CAFak. All immunoprecipitates contained comparable levels of CaFak protein as assessed by Western blot analysis.
|
|
DISCUSSION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We provide here the first evidence on the presence in C. albicans yeast cells of a p105Fak-like protein, which we termed CaFak, that is antigenically related to the vertebrate focal adhesion kinase p125Fak and on its involvement in the control of integrin-like mediated fungus adhesion to VN and to a human endothelial cell line.
CaFak has been identified by biochemical analysis with a number of different Abs directed against chicken Fak, as a protein of 105 kDa showing a faster electrophoretic mobility compared to p125Fak immunoprecipitated from lysates of EA.hy 926 human endothelial cell line. Immunofluorescence and cytofluorimetric analysis on permeabilized C. albicans yeast cells indicate that Abs that recognize p125Fak, specifically stain the majority (ca. 70%) of C. albicans yeast cells. In addition, confocal laser scanning microscopy analysis demonstrates that CaFak has a cytosolic distribution.
The presence in C. albicans of a Fak-like protein is not surprising in that Fak PTK is evolutionarily conserved and its expression is not restricted to mammalian cells. cDNAs encoding p125Fak have been isolated from human (52), rodent (22), chicken (42), Xenopus (54), and Drosophila (17),and analysis of their sequences shows a high level of homology between the different species.
Tyrosine phosphorylation of cellular proteins is a primary response to integrin stimulation and a role for PTKs belonging to the Fak family in the control of cellular adhesion and migration in vertebrates has been widely documented (8, 11, 15, 19, 36, 43). Moreover, it has been recently reported in Entamoeba histolytica, a protozoan expressing ß1 and ß2 integrin-like receptors (46, 51), that the adhesion of trophozoites to collagen I induces increased tyrosine phosphorylation of a 110-kDa ppFak-like protein (37). Similarly, in Hartmanella vermiformis, a basally tyrosine phosphorylated pp125Fak-like protein homologue to mammalian p125Fak that undergoes dephosphorylation upon protozoan attachment and invasion of Legionella pneumophila, has been reported (50).
Nothing is known about the involvement of similar PTK in fungus cell adhesion, although phosphotyrosine proteins of fungal origin were identified in ß-mercaptoethanol extracts of C. albicans upon adhesion to human buccal epithelial cells (2).
Our study provides evidence that the Fak-like protein migrating at 105 kDa is likely involved in the control of integrin-like VNR-mediated C. albicans yeast cell adhesion to VN and EA.hy 926 endothelial cell line.We demonstrated by using the PTK inhibitors genistein and herbimycin A that tyrosine kinase activation is a primary event required for C. albicans yeast cell adhesion to VN and to the endothelial cell line. Moreover, confocal microscopy analysis on C. albicans yeast cells adherent to VN demonstrates that CaFak redistributes from the cytosol to focal adhesion sites and colocalizes with v, ß3, and ß5 integrin-like receptors. Our results also show that engagement of vß3 and vß5 integrin-like VNRs on C. albicans yeast cells mediated either by specific MAbs or the natural ligand VN stimulates the phosphorylation on tyrosine residues of CaFak, which is basally tyrosine phosphorylated with levels varying from experiment to experiment. Finally, pretreatment of C. albicans with herbimycin A completely nullified Candida adhesion-dependent stimulation of CaFak tyrosine phosphorylation.These results strongly resemble previous evidence in mammalian cells where cell adhesion to VN or clustering of vß3 and vß5 integrins trigger p125 Fak tyrosine phosphorylation (31, 55). Our findings also demonstrate that adhesion of C. albicans yeast cells to the EA.hy 926 human endothelial cell line specifically increases tyrosine phosphorylation of CaFak, which is completely blocked by herbimycin A pretreatment.
Vascular endothelium plays an important role during the initiation of hematogenous dissemination because blood-borne Candida microorganisms adhere to endothelial basement membrane and/or subendothelial ECM components and penetrate into the endothelial cell lining of the vasculature to gain access to tissue parenchyma (28, 56). We have reported that VN is an important adhesion molecule recognized by C. albicans on the human EA.hy 926 endothelial cell line (45) and that adhesion of C. albicans on germ tube phase to the EA.hy 926 endothelial cells is markedly blocked by anti-ß3 integrin subunit MAb, RGD-containing peptides, and heparin (41).
A role of CaFak in C. albicans yeast adhesion is also supported by the failure of VN to stimulate CaFak tyrosine phosphorylation in a mutant strain of C. albicans which shows normal levels of CaFak and VNR-like integrins and reduced adhesiveness to VN and human endothelial cell line, defective germ tube transition, and lower pathogenicity (13). Moreover, our data indicate that adhesion of C. albicans mutant strain to VN results in dephosphorylation of CaFak, suggesting that this adhesive event could activate tyrosine phosphatases.
These findings also suggest that CaFak may be implicated in the control of Candida adherence, hyphal transition, and fungus pathogenicity, and in this regard we have preliminary results showing increased CaFak tyrosine phosphorylation during C. albicans yeast-mycelial transition (G. Santoni et al., unpublished observations).
Our evidence is in accordance with recent reports demonstrating that a number of signaling events are involved in triggering the transition from the budding yeast to a more invasive filamentous form. Thus, disruption or mutations of C. albicans genes encoding Ras-related GTPase (CaRSR1), components of MAPK (HOG1, HST7, and MKC1) and PAK (CaCLA4 and CST20) families, or histidine kinase (CaHK1) result in a defect of hyphal formation, reduced adhesion to human endothelial cells, and impaired systemic dissemination (4, 16, 27, 30, 32, 53). Similarly, homologous deletion of C. albicans PI-3K gene (CaVPS34) generates a mutant strain that exhibits a delayed yeast-to-hyphae transition and a strongly decreased ability to adhere to mouse fibroblasts (4).
Overall, these results indicate that CaFak, the Fak-like protein expressed in C. albicans yeast cells, may be involved in the regulation of Candida adhesiveness to VN and endothelial cells. Our results with the agerminative mutant of C. albicans that exhibits reduced adhesiveness and low virulence in systemic infection also suggest that CaFak tyrosine phosphorylation signals could be involved in the regulation of hyphal transition and, consequently, in the control of invasiveness and pathogenicity of C. albicans yeasts.
Strategies aimed at reducing Fak-like tyrosine phosphorylation by interfering with integrin-like mediated yeast cell adhesion to host components may be an attractive target for the development of antifungal therapies.
|
ACKNOWLEDGMENTS |
|---|
v and anti-ß3 integrins and the anti-Fak Abs. This research was supported by a grant obtained from MURST 2000 from the University of Camerino.
|
FOOTNOTES |
|---|
|
REFERENCES |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
| 1. | Akiyama, T., and H. Ogawara. 1998. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201:553-561. |
| 2. | Bailey, A., E. Wadsworth, and R. Calderone. 1995. Adherence of Candida albicans to human buccal epithelial cells: host-induced protein synthesis and signaling events. Infect. Immun. 63:569-572.[Abstract] |
| 3. | Blanchard, M. M., and V. Nowotny. 1994. High throughput rapid yeast DNA extraction: application to yeast artificial chromosomes as polymerase chain reaction templates. Genet. Anal. Tech. Appl. 11:7-11.[Medline] |
| 4. | Bruckmann, A., W. Kunkel, A. Hartl, R. Wetzker, and R. Eck. 2000. A phosphatidylinositol 3-kinase of Candida albicans influences adhesion, filamentous growth, and virulence. Microbiology 146:2755-2764. |
| 5. | Burridge, C. A., C. Turner, and L. Romer. 1992. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J. Cell Biol. 119:893-904. |
| 6. | Calderone, R. A., and P. C. Braun. 1991. Adherence and receptor relationships in Candida albicans. Microbiol. Rev. 55:1-20. |
| 7. | Calera, J. A., X. J. Zhao, F. De Bernardis, M. Sheridan, and R. Calderone. 1999. Avirulence of Candida albicans CaHK1 mutants in a murine model of hematogenously disseminated candidiasis. Infect. Immun. 67:4280-4284. |
| 8. | Cary, L. A., and J. L. Guan. 1999. Focal adhesion kinase in integrin-mediated signaling. Front. Biosci. 4:102-113. |
| 9. | Casanova, M., and W. L. Chaffin. 1991. Phosphate-containing proteins and glycoproteins of the cell wall of Candida albicans. Infect. Immun. 59:808-813. |
| 10. | Cassone, A., E. Mason, and D. Kerridge. 1981. Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study. Sabouraudia 19:97-110.[Medline] |
| 11. | Clark, E. A., and J. S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233-239. |
| 12. | Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218.[CrossRef][Medline] |
| 13. | De Bernardis, F., D. Adriani, R. Lorenzini, E. Pontieri, G. Carruba, and A. Cassone. 1993. Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection. Infect. Immun. 61:1500-1508. |
| 14. | Defilippi, P., C. Bozzo, G. Volpe, G. Romano, M. Venturino, L. Silengo, and G. Tarone. 1994. Integrin-mediated signal transduction in human endothelial cells: analysis of tyrosine phosphorylation events. Cell Adhesion Commun. 2:75-86.[Medline] |
| 15. | Defilippi, P., A. Gismondi, A. Santoni, and G. Tarone. 1997. Activation of tyrosine kinases, p. 29-59. In S. Ghosh (ed.), Signal transduction by integrins. Springer-Verlag, Heiderberg, Germany. |
| 16. | Diez-Orejas, R., G. Molero, F. Navarro-Garcia, J. Pla, C. Nombela, and M. Sanchez-Perez. 1997. Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen-activated protein kinase in pathogenesis. Infect. Immun. 65:833-837.[Abstract] |
| 17. | Fox, G. L., I. Rebay, and R. O. Hynes. 1999. Expression of DFak56, a Drosophila homolog of vertebrate focal adhesion kinase, supports a role in cell migration in vivo. Proc. Natl. Acad. Sci. USA 96:14978-14983. |
| 18. | Gale, C., D. Finkel, N. Tao, M. Meinke, M. McClellan, J. Olson, K. Kendrick, and M. K. Hostetter. 1996. Cloning and expression of a gene encoding an integrin-like protein in Candida albicans. Proc. Natl. Acad. Sci. USA 93:357-361. |
| 19. | Giancotti, T., and E. Ruoslahti. 1999. Integrin signaling. Science 285:1028-1032. |
| 20. | Gilmore, A. P., and L. H. Romer. 1996. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesion decreases cell motility and proliferation. Mol. Biol. Cell 7:1209-1224.[Abstract] |
| 21. | Gismondi, A., J. Jacobelli, F. Mainiero, R. Paolini, M. Piccoli, L. Frati, and A. Santoni. 2000. Functional role for proline-rich tyrosine kinase 2 in NK cell-mediated natural cytotoxicity. J. Immunol. 164:2272-2276. |
| 22. | Hanks, S. K., M.B Calalb, M. C. Harper, and S. K. Patel. 1992. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc. Natl. Acad. Sci. USA 89:8487-8491. |
| 23. | Hostetter, M. K. 1994. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin. Microbiol. Rev. 7:29-42. |
| 24. | Hostetter, M. K. 2000. RGD-mediated adhesion in fungal pathogens of humans, plants, and insects. Curr. Opin. Microbiol. 3:344-348.[CrossRef][Medline] |
| 25. | Hynes, R. O. 1993. Integrins: versatility, modulation and signalling in cell adhesion. Cell 69:11-25. |
| 26. | Ilic, D., Y. Furuta, S. Kanazawa, N. Takeda, K. Sobue, N. Nakatsuji, S. Nomura, J. Fujimoto, M. Okada, T. Yamamoto, and S. Aizawa. 1995. Reduced cell motility and enhanced focal contact formation in cells from FAK-deficient mice. Nature 377:539-544.[CrossRef][Medline] |
| 27. | Jong, A. Y., M. F. Stings, S. H. Huang, S. H. M. Chen, and K. S. Kim. 2001. Traversal of Candida albicans accross human blood-brain barrier in vitro. Infect. Immun. 69:4536-4544. |
| 28. | Klotz, S. A., D. J. Drutz, J. L. Harrison, and M. Hupper. 1983. Adherence and penetration of vascular endothelium by Candida yeasts. Infect. Immun. 42:374-384. |
| 29. | Kornberg, L., H. S. Earp, J. T. Parsons, M. Schaller, and R. L. Juliano. 1992. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J. Biol. Chem. 267:23439-23442. |
| 30. | Leberer, E., K. Ziegelbauer, A. Schimdt, D. Harcus, D. Dignard, J. Ash, L. Johnson, and D. Y. Thomas. 1997. Virulence and hyphal formation of Candida albicans require the Ste20p-like protein kinase CaCla4p. Curr. Biol. 7:539-546.[CrossRef][Medline] |
| 31. | Lewis, J. M., D. A. Cheresh, and M. A. Schwartz. 1996. Protein kinase C regulates vß5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation. J. Cell Biol. 134:1323-1332. |
| 32. | Madhani, H. D., and G. R. Fink. 1998. The control of filamentous differentiation and virulence in fungi. Trends Cell Biol. 8:348-353.[CrossRef][Medline] |
| 33. | Meri, S., P. Matila, and R. Renkonen. 1993. Regulation of CD59 expression on the human endothelial cell line EA.hy 926. Eur. J. Immunol. 23:2511-2516.[Medline] |
| 34. | Odds, F. C. 1988. Candida and candidosis, 2nd ed. Balliere Tindall, London, England. |
| 35. | Owen, J. D., P. J. Ruest, D. W. Fry, and S. K. Hanks. 1999. Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2. Mol. Cell. Biol. 19:4806-4818. |
| 36. | Parsons, J. T., K. H. Martin, J. K. Slack, J. M. Taylor, and S. A. Weed. 2000. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19:5606-5613.[CrossRef][Medline] |
| 37. | Perez, E., M. L. Munoz, and A. Ortega. 1996. Entamoeba histolytica: involvement of pp125FAK in collagen-induced signal transduction. Exp. Parasitol. 82:164-170.[CrossRef][Medline] |
| 38. | Ruoslahti, E. 1991. Integrins. J. Clin. Investig. 87:1-5. |
| 39. | Santoni, G., A. Gismondi, L. Jin Hong, A. Puntirieri, A. Santoni, L. Frati, M. Piccoli, and J. Y. Djeu. 1994. Candida albicans expresses a fibronectin receptor antigenically related to 5ß1 integrin. Microbiology 140:2971-2979.[Abstract] |
| 40. | Santoni, G., P. Birarelli, L. Jin Hong, A. Gamero, J. Y. Djeu, and M. Piccoli. 1995. An 5ß1-like integrin receptor mediates the binding of less pathogenic Candida species to fibronectin. J. Med. Microbiol. 43:360-367.[Abstract] |
| 41. | Santoni, G., E. Spreghini, R. Lucciarini, C. Amantini, and M. Piccoli. 2001. Involvement of vß3 integrin-like receptor and glycosaminoglycans in Candida albicans germ tube adhesion to vitronectin and human endothelial cell line. Microb. Pathog. 31:159-172.[CrossRef][Medline] |
| 42. | Schaller, M. D., C. A. Borgman, B. S. Cobb, R. R. Vines, A. B. Reynolds, and J. T. Parsons. 1992. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA 89:5192-5196. |
| 43. | Schlaepfer, D. D., and T. Hunter. 1998. Integrin signalling and tyrosine phosphorylation: just the FAK? Trends Cell Biol. 8:151-157.[CrossRef][Medline] |
| 44. | Schlaepfer, D. D., C. R. Hauck, and D. J. Sieg. 1999. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71:435-478.[CrossRef][Medline] |
| 45. | Spreghini, E., A. Gismondi, M. Piccoli, and G. Santoni. 1999. Evidence for vß3 and vß5 integrin-like vitronectin (VN) receptors in Candida albicans and their involvement in yeast cell adhesion to VN. J. Infect. Dis. 180:156-166.[CrossRef][Medline] |
| 46. | Talamas-Rohana, P., V. I. Hernandez-Ramirez, J. N. Perez-Garcia, and J. Ventura-Juarez. 1998. Entamoeba histolytica contains a ß1 integrin-like molecule similar to fibronectin receptors from eukaryotic cells. J. Eukaryot. Microbiol. 45:356-360.[Medline] |
| 47. | Tamura, M. J., J. Gu, K. Matsumoto, S. Aota, R. Parsons, and K. M. Yamada. 1998. Inhibition of cell migration, spreading and focal adhesion by tumor suppressor PTEN. Science 280:1614-1617. |
| 48. | Torosantucci, A., M. Boccanera, I. Casalinuovo, G. Pellegrini, and A. Cassone. 1990. Differences in the antigenic expression of immunomodulatory mannoprotein constituens on yeast and mycelial forms of Candida albicans. J. Gen. Microbiol. 136:1421-1428.[Medline] |
| 49. | Uehara, Y., and H. Fuzawaka. 1991. Use and selectivity of hermimycin A as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201:563-571. |
| 50. | Venkataraman, C., L. Y. Gao, S. Bondada, and Y. A. Kwaik. 1998. Identification of putative cytoskeletal protein homologues in the protozoan host Hartmanella vermiformis as substrates for induced tyrosine phosphatase activity upon attachment to the Legionnaires' Disease bacterium, Legionnaires pneumophila. J. Exp. Med. 188:505-514. |
| 51. | Vines, R. R., G. Ramakrishnan, J. B. Rogers, L. A. Lockhart, B. J. Mann, and W. A. Petri, Jr. 1998. Regulation of adherence and virulence by the Entamoeba histolytica lectin cytoplasmic domain, which contains a ß2 integrin motif. Mol. Biol. Cell 9:2069-2079. |
| 52. | Weiner, T. M., E. T. Liu, R. J. Craven, and W. G. Cance. 1993. Expression of focal adhesion kinase gene and invasive cancer. Lancet 342:1024-1025.[CrossRef][Medline] |
| 53. | Yaar, L., M. Mevarech, and Y. Koltin. 1997. A Candida albicans RAS-related gene (CaRSR1) is involved in budding, cell morphogenesis and hypha development. Microbiology 143:3033-3044.[Abstract] |
| 54. | Zhang, X., C. V. Wright, and S. K. Hanks. 1995. Cloning of a Xenopus laevis cDNA encoding focal adhesion kinase (FAK) and expression during early development. Gene 160:219-222.[CrossRef][Medline] |
| 55. | Zheng, D. Q., A. S. Woodard, G. Tallini, and L. R. Languino. 2000. Substrate specificity of vß3 integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation. J. Biol. Chem. 275:24565-24574. |
| 56. | Zink, S., T. Nass, P. Rosen, and J. F. Ernst. 1996. Migration of fungal pathogen Candida albicans across endothelial monolayers. Infect. Immun. 64:5085-5091.[Abstract] |
This article has been cited by other articles:
| ||||||||||||
) evaluated in the absence (control medium) or presence of different doses of genistein (A), herbimycin A (B), or vehicle (DMSO) (data not shown) at 30 min after incubation at 37°C. Results are the mean percent specific inhibition ± the standard deviation (three separate experiments). The mean percent cell yeast adhesions to VN and EA.hy 926 cells were 48 ± 1 and 63 ± 2, respectively. Since no differences were observed between adhesion in the presence of control medium and vehicle, only data in the presence of medium are shown for sake of simplicity.
) or 3153 mutant (
) yeast cells were stained with anti-Fak COOH polyclonal Ab or anti-Fak NH2 MAb after permeabilization, and unpermeabilized cells were stained with anti-
, P < 0.01.